RCEL (Avita Medical, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by RCEL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | David D O'Toole | CFO | Buy | — | — |
| 2026-06-12 | David D O'Toole | CFO | A | — | — |
| 2026-06-10 | Joseph Fralin Woody | Director | Buy | — | — |
| 2026-06-09 | Joseph Fralin Woody | Director | Buy | — | — |
| 2026-06-05 | Joseph Fralin Woody | Director | Buy | — | — |
| 2026-06-04 | Robert McNamara | Director | A | — | — |
| 2026-06-04 | JEREMY CURNOCK COOK | Director | A | — | — |
| 2026-06-04 | Michael E Tarnoff | Director | A | — | — |
| 2026-06-04 | Suzanne Crowe | Director | A | — | — |
| 2026-06-04 | JAN STERN REED | Director | A | — | — |
| 2026-06-04 | Joseph Fralin Woody | Director | A | — | — |
| 2026-06-03 | Joseph Fralin Woody | Director | Buy | — | — |
| 2026-06-01 | David D O'Toole | CFO | A | — | — |
| 2026-06-01 | Cary Guy Vance | President and CEO | A | — | — |
| 2026-05-20 | David D O'Toole | CFO | Buy | — | — |
| 2026-05-19 | David D O'Toole | CFO | Buy | — | — |
| 2026-03-11 | David D O'Toole | CFO | Buy | — | — |
| 2026-02-23 | David D O'Toole | CFO | Buy | — | — |
| 2026-02-19 | NICOLE KELSEY | Chief Legal Officer | A | — | — |
| 2026-02-19 | David D O'Toole | CFO | A | — | — |
| 2025-08-29 | Robert McNamara | Director | Buy | — | — |
| 2025-08-26 | David D O'Toole | CFO | Buy | — | — |
| 2025-08-20 | Robert McNamara | Director | Buy | — | — |
| 2025-08-12 | David D O'Toole | CFO | Buy | — | — |
| 2025-06-05 | Robert McNamara | Director | A | — | — |
| 2025-06-05 | Suzanne Crowe | Director | A | — | — |
| 2025-06-05 | Cary Guy Vance | Director | A | — | — |
| 2025-06-05 | JEREMY CURNOCK COOK | Director | A | — | — |
| 2025-06-05 | JAMES CORBETT | CEO | A | — | — |
| 2025-06-05 | JAN STERN REED | Director | A | — | — |
| 2025-06-05 | Lou Panaccio | Director | A | — | — |
| 2025-06-02 | David D O'Toole | CFO | A | — | — |
| 2025-03-10 | Robert McNamara | Director | Buy | — | — |
| 2025-02-20 | Robert McNamara | Director | Buy | — | — |
| 2025-02-20 | David D O'Toole | CFO | Buy | — | — |
| 2025-02-19 | David D O'Toole | CFO | Buy | — | — |
| 2025-01-29 | Suzanne Crowe | Director | Buy | — | — |
| 2025-01-22 | NICOLE KELSEY | Chief Legal Officer | A | — | — |
| 2025-01-22 | David D O'Toole | CFO | A | — | — |
| 2024-12-05 | David D O'Toole | CFO | MIXED | — | — |
| 2024-08-20 | Robert McNamara | Director | A | — | — |
| 2024-06-06 | Suzanne Crowe | Director | A | — | — |
| 2024-06-06 | JAMES CORBETT | CEO | A | — | — |
| 2024-06-06 | JAN STERN REED | Director | A | — | — |
| 2024-06-06 | Robert McNamara | Director | A | — | — |
| 2024-06-06 | JEREMY CURNOCK COOK | Director | A | — | — |
| 2024-06-06 | Cary Guy Vance | Director | A | — | — |
| 2024-06-06 | Lou Panaccio | Director | A | — | — |
| 2024-06-03 | Donna Shiroma | General Counsel | A | — | — |
| 2024-06-03 | David D O'Toole | CFO | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 406,525 | — |
| — | CFO | 152,927 | — |
| — | Director | 108,985 | — |
| — | Director | 107,961 | — |
| — | Chief Legal Officer | 98,390 | — |
| — | Director | 73,225 | — |
| — | Director | 69,148 | — |
| — | Director | 62,400 | — |
| — | Director | 62,050 | — |
| — | Chief Financial Officer | 46,450 | — |
| — | Chief Commercial Officer | 46,450 | — |
| — | Chief Technology Officer | 46,450 | — |
| — | Chief Operating Officer | 46,450 | — |
| — | General Counsel | 45,951 | — |
| — | President and CEO | 40,771 | — |
| — | Director | 26,250 | — |
| — | CEO | 11,580 | — |
| — | Interim CFO | 5,000 | — |
| — | Director | 4,689 | — |
| — | Chief Financial Officer | 500 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RCEL quote page; the site-wide leaderboard is on the insider transactions hub.